143 related articles for article (PubMed ID: 37344705)
21. Capecitabine metronomic chemotherapy inhibits the proliferation of gastric cancer cells through anti-angiogenesis.
Yuan F; Shi H; Ji J; Cai Q; Chen X; Yu Y; Liu B; Zhu Z; Zhang J
Oncol Rep; 2015 Apr; 33(4):1753-62. PubMed ID: 25634241
[TBL] [Abstract][Full Text] [Related]
22. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
[TBL] [Abstract][Full Text] [Related]
23. Sorafenib inhibits 5-fluorouracil-resistant gastric cancer cell growth.
Kim HM; Kim SA; Park SB; Cho JH; Song SY
Scand J Gastroenterol; 2017 May; 52(5):577-584. PubMed ID: 28110575
[TBL] [Abstract][Full Text] [Related]
24. Effects of rosiglitazone on the growth and lymphangiogenesis of human gastric cancer transplanted in nude mice.
Chen FZ; Mo XM; Wang QP; Li J; Zhang L
Oncol Rep; 2013 Dec; 30(6):2705-12. PubMed ID: 24002492
[TBL] [Abstract][Full Text] [Related]
25. Antitumor activity of TY-011 against gastric cancer by inhibiting Aurora A, Aurora B and VEGFR2 kinases.
Liu W; Lu Y; Chai X; Liu X; Zhu T; Wu X; Fang Y; Liu X; Zhang X
J Exp Clin Cancer Res; 2016 Nov; 35(1):183. PubMed ID: 27887633
[TBL] [Abstract][Full Text] [Related]
26. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
[TBL] [Abstract][Full Text] [Related]
27. Pathway-related molecules of VEGFC/D-VEGFR3/NRP2 axis in tumor lymphangiogenesis and lymphatic metastasis.
Wang J; Huang Y; Zhang J; Wei Y; Mahoud S; Bakheet AM; Wang L; Zhou S; Tang J
Clin Chim Acta; 2016 Oct; 461():165-71. PubMed ID: 27527412
[TBL] [Abstract][Full Text] [Related]
28. Angiogenic factor thymidine phosphorylase associates with angiogenesis and lymphangiogenesis in the intestinal-type gastric cancer.
Zhang X; Zheng Z; Shin YK; Kim KY; Rha SY; Noh SH; Chung HC; Jeung HC
Pathology; 2014 Jun; 46(4):316-24. PubMed ID: 24798152
[TBL] [Abstract][Full Text] [Related]
29. Extract of
Cui XL; Li KJ; Ren HX; Zhang YJ; Liu XD; Bu BG; Wang L
World J Gastroenterol; 2019 Apr; 25(15):1854-1864. PubMed ID: 31057299
[TBL] [Abstract][Full Text] [Related]
30. Anti-metastatic Efficacy of Traditional Chinese Medicine (TCM) Ginsenoside Conjugated to a VEFGR-3 Antibody on Human Gastric Cancer in an Orthotopic Mouse Model.
Dai X; Liu D; Liu M; Zhang X; Wang W; Jin F; Qian Y; Wang X; Zhao J; Wu Y; Xiong F; Chang NA; Sun YU; Yang Z; Hoffman RM; Liu Y
Anticancer Res; 2017 Mar; 37(3):979-986. PubMed ID: 28314255
[No Abstract] [Full Text] [Related]
31. Intratumoral lymphangiogenesis and prognostic significance of VEGFC expression in gastric cancer.
Ikeda K; Oki E; Saeki H; Ando K; Morita M; Oda Y; Imamura M; Kakeji Y; Maehara Y
Anticancer Res; 2014 Aug; 34(8):3911-5. PubMed ID: 25075012
[TBL] [Abstract][Full Text] [Related]
32. IL-6 mediates the signal pathway of JAK-STAT3-VEGF-C promoting growth, invasion and lymphangiogenesis in gastric cancer.
Zhao G; Zhu G; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Ye J
Oncol Rep; 2016 Mar; 35(3):1787-95. PubMed ID: 26750536
[TBL] [Abstract][Full Text] [Related]
33. Peri-tumor administration of 5-fluorouracil sol-gel using a hollow microneedle for treatment of gastric cancer.
Jung YS; Koo DH; Yang JY; Lee HY; Park JH; Park JH
Drug Deliv; 2018 Nov; 25(1):872-879. PubMed ID: 29608119
[TBL] [Abstract][Full Text] [Related]
34. Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil.
Wang J; Hu W; Wang K; Yu J; Luo B; Luo G; Wang W; Wang H; Li J; Wen J
Int J Oncol; 2016 Apr; 48(4):1341-52. PubMed ID: 26847910
[TBL] [Abstract][Full Text] [Related]
35. Wogonin potentiates the antitumor effects of low dose 5-fluorouracil against gastric cancer through induction of apoptosis by down-regulation of NF-kappaB and regulation of its metabolism.
Zhao Q; Wang J; Zou MJ; Hu R; Zhao L; Qiang L; Rong JJ; You QD; Guo QL
Toxicol Lett; 2010 Sep; 197(3):201-10. PubMed ID: 20570612
[TBL] [Abstract][Full Text] [Related]
36. [Effect of combination of docosahexaenoic acid and fluorouracil on human gastric carcinoma cell strain MGC803].
Wu Q; Yu JC; Liu YQ; Kang WM; Guo WD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Feb; 32(1):65-70. PubMed ID: 20236591
[TBL] [Abstract][Full Text] [Related]
37. Tumor Necrosis Factor-
Chen X; Lin L; Wu Q; Li S; Wang H; Sun Y
Mediators Inflamm; 2023; 2023():5679966. PubMed ID: 37124061
[TBL] [Abstract][Full Text] [Related]
38. Fucoxanthin inhibits gastric cancer lymphangiogenesis and metastasis by regulating Ran expression.
Wang J; Dong X; Li D; Fang Z; Wan X; Liu J
Phytomedicine; 2023 Sep; 118():154926. PubMed ID: 37392675
[TBL] [Abstract][Full Text] [Related]
39. SPARC enhances 5-FU chemosensitivity in gastric cancer by modulating epithelial-mesenchymal transition and apoptosis.
Ma J; Ma Y; Chen S; Guo S; Hu J; Yue T; Zhang J; Zhu J; Wang P; Chen G; Liu Y
Biochem Biophys Res Commun; 2021 Jun; 558():134-140. PubMed ID: 33910127
[TBL] [Abstract][Full Text] [Related]
40. Xiaotan Sanjie decoction attenuates tumor angiogenesis by manipulating Notch-1-regulated proliferation of gastric cancer stem-like cells.
Yan B; Liu L; Zhao Y; Xiu LJ; Sun DZ; Liu X; Lu Y; Shi J; Zhang YC; Li YJ; Wang XW; Zhou YQ; Feng SH; Lv C; Wei PK; Qin ZF
World J Gastroenterol; 2014 Sep; 20(36):13105-18. PubMed ID: 25278704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
